source
- Preoperative Intravesical Mitomycin-C Before TURBT Cuts Recurrence Risk by 77% in NMIBC Over 5 YearsTwo doses of intravesical mitomycin-C administered before TURBT produced a 77% reduction in the risk of recurrence or death vs TURBT alone in NMIBC.onclive · 2mo ago↗ source
- Genomic Disease Burden Markers, PD-L1 Expression Predictive of pOR With Neoadjuvant Gem-iDRS ± Cetrelimab in MIBCA biomarker analysis of SunRISe-4 found that high baseline TMB, GBD, and PD-L1 expression were associated with pathologic overall response to the regimen.onclive · 2mo ago↗ source
- Dr Croll on Radiographic Size Change vs irRVT After Neoadjuvant Therapy in RCCBenjamin Croll, MD, discusses findings from a study of the correlation between radiographic response and pathologic response in RCC.